HALEY CALLAHAN: Open Payments
NPI 1154969632 · NORTH ANDOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,166 in 184 payments from 20 companies in 2025. Trend: 2023 $2,137 · 2024 $4,460 · 2025 $4,166
Food & beverage: $3,779Education: $387
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $756 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $604 |
| ABBVIE INC. | 26 | $493 |
| GENZYME CORPORATION | 13 | $350 |
| UCB, Inc. | 9 | $218 |
| Lilly USA, LLC | 8 | $218 |
| Galderma Laboratories, L.P. | 17 | $211 |
| Amgen Inc. | 11 | $209 |
| Regeneron Healthcare Solutions, Inc. | 9 | $179 |
| PFIZER INC. | 10 | $156 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, ILUMYA, Bimzelx, OTEZLA, RINVOQ, TALTZ.
Industry payments across MA — which companies pay providers there.
